Microgestin Fe 1.5/30
Product Images NDC 53002-3567

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Microgestin Fe 1.5/30 (NDC 53002-3567). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 (Image 01)

FDA Label Image

2 (Image 02)

2 (Image 02)
This is a table showing the lowest expected and typical failure rates of various contraceptive methods during the first year of continuous use. The table includes methods such as oral contraceptives, diaphragm with spermicidal cream or jelly, spermicides alone, vaginal sponge, implant, injection, IUD, condom, cervical cap with spermicidal cream or jelly, periodic abstinence, withdrawal, female sterilization, and male sterilization. The percentages represent the likelihood of accidental pregnancy among couples who consistently and correctly use the method during the first year. The data is adapted from a reference source.*
FDA Label Image

3 (Image 03)

3 (Image 03)
Cigarette smoking is known to greatly increase the chances of experiencing severe cardiovascular complications while using oral contraceptives. This risk is more significant in older women, especially those who smoke heavily (15 or more cigarettes per day), and is particularly pronounced in women over 35 years old. Consequently, it is highly recommended that females who use oral contraceptives refrain from smoking.*
FDA Label Image

4 (Image 04)

FDA Label Image

5 (Image 05)

FDA Label Image

6 (Image 06)

6 (Image 06)
Cigarette smoking and oral contraceptive use can have serious cardiovascular side effects. Smoking increases this risk, especially for women over 35 years old and those who smoke heavily (15 or more cigarettes per day). It is strongly recommended that women who use oral contraceptives should avoid smoking.*
FDA Label Image

7 (Image 07)

7 (Image 07)
Microgestin Fe 1.5/30 is a birth control pill pack that contains 21 yellow pills for weeks 1, 2, and 3, and brown pills only for week 4. The pack is designed to be taken daily from left to right each week. It is important to follow the provided instructions for proper usage.*
FDA Label Image

8 (Image 08)

8 (Image 08)
Cigarette smoking is known to raise the chances of experiencing severe cardiovascular complications when using oral contraceptives. The risk escalates as individuals get older and smoke heavily (15 or more cigarettes daily), particularly in women above the age of 35. It is strongly recommended that women who use oral contraceptives refrain from smoking.*
FDA Label Image

9 (Image 09)

9 (Image 09)
Cigarette smoking can significantly increase the chances of experiencing severe cardiovascular complications when using oral contraceptives. This risk is particularly heightened in older women (over 35 years of age) and those who smoke heavily (15 or more cigarettes per day). It is highly recommended that women who use oral contraceptives refrain from smoking.*
FDA Label Image

10 (Image 10)

10 (Image 10)
ANNUAL NUMBER OF BIRTH-RELATED OR METHOD-RELATED DEATHS ASSOCIATED WITH CONTROL OF FERTILITY PER 100,000 NON-STERILE WOMEN BY FERTILITY CONTROL METHOD ACCORDING TO AGE This text provides data on the annual number of birth-related or method-related deaths associated with fertility control methods among non-sterile women. The data is categorized by age groups (15-19, 20-24, 25-29, 30-34, 35-39, and 40-44) and different methods of fertility control. The first section of the data shows the number of deaths for women using no fertility control methods, with varying numbers for each age group. The next sections show the number of deaths for women using oral contraceptives, specifically categorized as non-smokers and smokers. There is also data for deaths associated with an unidentified method called "TUD." Additionally, the text provides limited information on deaths related to other fertility control methods such as condoms, diaphragms/spermicides, and periodic abstinence. However, the data for these methods is incomplete and not available for all age groups. It is important to note that the text specifies that deaths mentioned are birth-related or method-related.*
FDA Label Image

11 (Image 11)

11 (Image 11)
Microgestin Fe 1.5/30 is a medication that comes in a pack containing 21 yellow pills for weeks 1, 2, and 3. Week 4 of the pack will contain only brown pills. The pack is designed to be taken from left to right each week.*
FDA Label Image

12 (Image 12)

FDA Label Image

Label Image (Lbl530023567)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.